iShares Neuroscience and HeaIBRNETF
13F holders, Q2 2026 (June 30)5holders
2new positions
1sold out
$38.83avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, unchanged from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were Steward Partners Investment Advisory, LLC ($825K), BlackRock, Inc. ($582K) and UBS Group AG ($8K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7K |
| Exits | 1 | $98 |
All 13F filers, Q1 2026 → Q2 2026: 320 shares bought and 31,205 shares sold, net −30,885 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -0.9% | 21,257 | $825K |
| BlackRock, Inc. | 0.00% | Reduce -67.4% | 15,000 | $582K |
| UBS Group AG | 0.00% | Add +197.0% | 199 | $8K |
| Assetmark, Inc. | 0.00% | New | 100 | $4K |
| Institute for Wealth Management, LLC. | 0.00% | New | 88 | $3K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.